Electromagnetic localization technology developer Calypso Medical Technologies has commenced the first clinical study evaluating its Calypso system for lung cancer radiation therapy tracking.
The study will also include a new design of the Seattle-based firm's implantable Beacon transponder. Tygerberg Hospital of Cape Town, South Africa, is the initial clinical site, Calypso said.
Related Reading
Calypso nets FDA OK on gating feature, October 12, 2010
Calypso signs European sales pact with Siemens, September 2, 2010
Calypso wraps up first U.K. install, March 17, 2010
Calypso closes $50M funding, September 18, 2009
Calypso aligns with Varian Medical, July 24, 2009
Copyright © 2010 AuntMinnie.com
